Opdivo 100 mg & 40 mg

Opdivo

Nivolumab (Inj Opdivo 100 mg & 40 mg) by Bristol - Myers Squibb is a cancer medicine that works with your
immune system to interfere with the growth and spread of cancer cells in the body. Nivolumab may increase
the chance of a longer survival time in people with this type of lung cancer.

Opdivo is used to treat a certain type of melanoma (skin cancer) that cannot be treated with surgery, or that
has spread to other parts of the body.

Indication :

Opdivo is indicated to treat a certain type of non - small cell lung cancer. Nivolumab may increase the chance of
a longer survival time in people with this type of lung cancer.